Although the reason for high expression of ANO1 in tumors is unclear, several studies have shown that ANO1 is involved in oncogenic signaling by activating EGFR and CAMK pathways to promote cell cycle and cancer progression [30, 37]. This evidence concerns the gene EGFR and cancer.